Cargando…
Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo
Fibroblast growth factors 19 (FGF19) and 21 (FGF21) have emerged as key regulators of energy metabolism. Several studies have been conducted to understand the mechanism of FGF19 and FGF21 action, however, the data presented has often been inconsistent and at times contradictory. Here in a single stu...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365001/ https://www.ncbi.nlm.nih.gov/pubmed/22675463 http://dx.doi.org/10.1371/journal.pone.0038438 |
_version_ | 1782234622728339456 |
---|---|
author | Adams, Andrew C. Coskun, Tamer Irizarry Rovira, Armando R. Schneider, Michael A. Raches, David W. Micanovic, Radmila Bina, Holly A. Dunbar, James D. Kharitonenkov, Alexei |
author_facet | Adams, Andrew C. Coskun, Tamer Irizarry Rovira, Armando R. Schneider, Michael A. Raches, David W. Micanovic, Radmila Bina, Holly A. Dunbar, James D. Kharitonenkov, Alexei |
author_sort | Adams, Andrew C. |
collection | PubMed |
description | Fibroblast growth factors 19 (FGF19) and 21 (FGF21) have emerged as key regulators of energy metabolism. Several studies have been conducted to understand the mechanism of FGF19 and FGF21 action, however, the data presented has often been inconsistent and at times contradictory. Here in a single study we compare the mechanisms mediating FGF19/FGF21 actions, and how similarities/differences in actions at the cellular level between these two factors translate to common/divergent physiological outputs. Firstly, we show that in cell culture FGF19/FGF21 are very similar, however, key differences are still observed differentiating the two. In vitro we found that both FGF's activate FGFRs in the context of βKlotho (KLB) expression. Furthermore, both factors alter ERK phosphorylation and glucose uptake with comparable potency. Combination treatment of cells with both factors did not have additive effects and treatment with a competitive inhibitor, the FGF21 delta N17 mutant, also blocked FGF19's effects, suggestive of a shared receptor activation mechanism. The key differences between FGF21/FGF19 were noted at the receptor interaction level, specifically the unique ability of FGF19 to bind/signal directly via FGFR4. To determine if differential effects on energy homeostasis and hepatic mitogenicity exist we treated DIO and ob/ob mice with FGF19/FGF21. We find comparable efficacy of the two proteins to correct body weight and serum glucose in both DIO and ob/ob mice. Nevertheless, FGF21 and FGF19 had distinctly different effects on proliferation in the liver. Interestingly, in vivo blockade of FGF21 signaling in mice using ΔN17 caused profound changes in glycemia indicative of the critical role KLB and FGF21 play in the regulation of glucose homeostasis. Overall, our data demonstrate that while subtle differences exist in vitro the metabolic effects in vivo of FGF19/FGF21 are indistinguishable, supporting a shared mechanism of action for these two hormones in the regulation of energy balance. |
format | Online Article Text |
id | pubmed-3365001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-33650012012-06-06 Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo Adams, Andrew C. Coskun, Tamer Irizarry Rovira, Armando R. Schneider, Michael A. Raches, David W. Micanovic, Radmila Bina, Holly A. Dunbar, James D. Kharitonenkov, Alexei PLoS One Research Article Fibroblast growth factors 19 (FGF19) and 21 (FGF21) have emerged as key regulators of energy metabolism. Several studies have been conducted to understand the mechanism of FGF19 and FGF21 action, however, the data presented has often been inconsistent and at times contradictory. Here in a single study we compare the mechanisms mediating FGF19/FGF21 actions, and how similarities/differences in actions at the cellular level between these two factors translate to common/divergent physiological outputs. Firstly, we show that in cell culture FGF19/FGF21 are very similar, however, key differences are still observed differentiating the two. In vitro we found that both FGF's activate FGFRs in the context of βKlotho (KLB) expression. Furthermore, both factors alter ERK phosphorylation and glucose uptake with comparable potency. Combination treatment of cells with both factors did not have additive effects and treatment with a competitive inhibitor, the FGF21 delta N17 mutant, also blocked FGF19's effects, suggestive of a shared receptor activation mechanism. The key differences between FGF21/FGF19 were noted at the receptor interaction level, specifically the unique ability of FGF19 to bind/signal directly via FGFR4. To determine if differential effects on energy homeostasis and hepatic mitogenicity exist we treated DIO and ob/ob mice with FGF19/FGF21. We find comparable efficacy of the two proteins to correct body weight and serum glucose in both DIO and ob/ob mice. Nevertheless, FGF21 and FGF19 had distinctly different effects on proliferation in the liver. Interestingly, in vivo blockade of FGF21 signaling in mice using ΔN17 caused profound changes in glycemia indicative of the critical role KLB and FGF21 play in the regulation of glucose homeostasis. Overall, our data demonstrate that while subtle differences exist in vitro the metabolic effects in vivo of FGF19/FGF21 are indistinguishable, supporting a shared mechanism of action for these two hormones in the regulation of energy balance. Public Library of Science 2012-05-31 /pmc/articles/PMC3365001/ /pubmed/22675463 http://dx.doi.org/10.1371/journal.pone.0038438 Text en Adams et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Adams, Andrew C. Coskun, Tamer Irizarry Rovira, Armando R. Schneider, Michael A. Raches, David W. Micanovic, Radmila Bina, Holly A. Dunbar, James D. Kharitonenkov, Alexei Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo |
title | Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo
|
title_full | Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo
|
title_fullStr | Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo
|
title_full_unstemmed | Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo
|
title_short | Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo
|
title_sort | fundamentals of fgf19 & fgf21 action in vitro and in vivo |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365001/ https://www.ncbi.nlm.nih.gov/pubmed/22675463 http://dx.doi.org/10.1371/journal.pone.0038438 |
work_keys_str_mv | AT adamsandrewc fundamentalsoffgf19fgf21actioninvitroandinvivo AT coskuntamer fundamentalsoffgf19fgf21actioninvitroandinvivo AT irizarryroviraarmandor fundamentalsoffgf19fgf21actioninvitroandinvivo AT schneidermichaela fundamentalsoffgf19fgf21actioninvitroandinvivo AT rachesdavidw fundamentalsoffgf19fgf21actioninvitroandinvivo AT micanovicradmila fundamentalsoffgf19fgf21actioninvitroandinvivo AT binahollya fundamentalsoffgf19fgf21actioninvitroandinvivo AT dunbarjamesd fundamentalsoffgf19fgf21actioninvitroandinvivo AT kharitonenkovalexei fundamentalsoffgf19fgf21actioninvitroandinvivo |